Saadettin Kilickap
Istinye, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 214 publications
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature.
Journal: Clinical genitourinary cancer
Published: May 03, 2026
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.
Journal: JAMA oncology
Published: April 30, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.
Journal: JCO global oncology
Published: March 19, 2026
Prognostic Significance of SULF2 Expression in Surgically Resected Non-Small Cell Lung Cancer.
Journal: Medical sciences (Basel, Switzerland)
Published: March 02, 2026
Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 01, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.
Journal: Journal of clinical medicine
Published: March 01, 2026
Continued Cemiplimab Beyond Progression With Addition of Chemotherapy in Patients With Advanced NSCLC With PD-L1 Expression of 50% or Higher: 5-Year Follow-Up From EMPOWER-Lung 1.
Journal: JTO clinical and research reports
Published: February 27, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.
Journal: Scientific reports
Published: February 20, 2026
Last Updated: 09/26/2026